Contact
Please use this form to send email to PR contact of this press release:
Gilenya (fingolimod) - Drug Safety Communication: Investigating Rare Brain Infection
TO:
Please use this form to send email to PR contact of this press release:
Gilenya (fingolimod) - Drug Safety Communication: Investigating Rare Brain Infection
TO: